AI News HubAI News Hub
TodayNewsToolsIdeasTrends
Admin
TodayNewsToolsIdeasTrends

The AI brief, in your inbox

One email. The morning brief, new tools and where AI is heading — free.

AI News Hub — Daily AI news, tools, trends and ideas, curated by ClaudeNews, tools, trends & ideas — updated twice daily at 5am & 4pmRSSAdmin
Back to News
AI

Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

VentureBeat AI·August 7, 2026·1 min read
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

AI Summary

Stanford University is utilizing 37,000 AI agents to function as a virtual biotech, with one of its drug designs receiving independent confirmation from Merck. James Zou emphasized that the future of AI development will focus on the collaboration of numerous agents rather than on creating a single, more advanced model.

From the source

For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about to break: the next frontier isn't a single, more capable agent, it's tens of thousands of them collaborating. For developers and product builders, the most critical takeaway from Zou’s presentation is how these massive systems are orchestrated. Hi

The full text couldn't be loaded here (the source may require a subscription).

View original at VentureBeat AI

Keep reading

OpenAI Delays Development of Next-Gen AI 'Astra' Due to Cybersecurity Concernszdnet.co.kr · 3h agoCFOs prioritize technology and AI, indicates Grant Thorntonterra.com.br · 3h agoAI's Reach Has Extended to HR Departments... "If Roles Are Not Redefined, Extinction Is Inevitable"joongang.co.kr · 3h agoCan we detect AI-generated deepfake videos and voices?dongascience.com · 3h ago
Was this useful?